Jaguar Health Files Proxy Materials
Ticker: JAGX · Form: DEFA14A · Filed: Aug 6, 2025 · CIK: 1585608
| Field | Detail |
|---|---|
| Company | Jaguar Health, INC. (JAGX) |
| Form Type | DEFA14A |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, proxy-statement
TL;DR
Jaguar Health filed proxy docs, no fee needed.
AI Summary
Jaguar Health, Inc. filed a Definitive Additional Materials (DEFA14A) on August 6, 2025. This filing is related to their proxy statement and indicates no fee was required for this filing. The company, formerly known as Jaguar Animal Health, Inc., is based in San Francisco, CA.
Why It Matters
This filing is a routine regulatory submission for Jaguar Health, Inc., providing updated information to shareholders regarding proxy matters.
Risk Assessment
Risk Level: low — This filing is a standard regulatory disclosure and does not present immediate financial risk.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- Jaguar Animal Health, Inc. (company) — Former company name
- 200 PINE STREET SUITE 400 (address) — Business and Mail Address
- SAN FRANCISCO (location) — City
- CA (location) — State
- 94104 (zip_code) — Zip Code
- 415-371-8300 (phone_number) — Business Phone
- 0001193125-25-174505 (filing_id) — Accession Number
- 20250806 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials'.
Who is the filing company?
The filing company is Jaguar Health, Inc.
When was this filing submitted?
The filing was submitted on August 6, 2025.
Was there a filing fee associated with this submission?
No fee was required for this filing.
What was the company's former name?
The company's former name was Jaguar Animal Health, Inc., with a date of name change on August 30, 2013.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on August 6, 2025 regarding Jaguar Health, Inc. (JAGX).